Nigrostriatal lesion induces D2-modulated phase-locked activity in the basal ganglia of rats

Archive ouverte

Zold, Camila | Ballion, Bérangère | Riquelme, Luis | Gonon, François | Murer, M Gustavo

Edité par CCSD ; Wiley -

International audience. There is a debate as to what modifications of neuronal activity underlie the clinical manifestations of Parkinson's disease and the efficacy of antiparkinsonian pharmacotherapy. Previous studies suggest that release of GABAergic striatopallidal neurons from D2 receptor-mediated inhibition allows spreading of cortical rhythms to the globus pallidus (GP) in rats with 6-hydroxydopamine-induced nigrostriatal lesions. Here this abnormal spreading was thoroughly investigated. In control urethane-anaesthetized rats most GP neurons were excited during the active part of cortical slow waves ('direct-phase' neurons). Two neuronal populations having opposite phase relationships with cortical and striatal activity coexisted in the GP of 6-hydroxydopamine-lesioned rats. 'Inverse-phase' GP units exhibited reduced firing coupled to striatal activation during slow waves, suggesting that this GP oscillation was driven by striatopallidal hyperactivity. Half of the pallidonigral neurons identified by antidromic stimulation exhibited inverse-phase activity. Therefore, spreading of inverse-phase oscillations through pallidonigral axons might contribute to the abnormal direct-phase cortical entrainment of basal ganglia output described previously. Systemic administration of the D2 agonist quinpirole to 6-hydroxydopamine-lesioned rats reduced GP inverse-phase coupling with slow waves, and this effect was reversed by the D2 antagonist eticlopride. Because striatopallidal hyperactivity was only slightly reduced by quinpirole, other mechanisms might have contributed to the effect of quinpirole on GP oscillations. These results suggest that antiparkinsonian efficacy may rely on other actions of D2 agonists on basal ganglia activity. However, abnormal slow rhythms may promote enduring changes in functional connectivity along the striatopallidal axis, contributing to D2 agonist-resistant clinical signs of parkinsonism.

Consulter en ligne

Suggestions

Du même auteur

D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism

Archive ouverte | Ballion, Bérangère | CCSD

International audience. In Parkinson's disease dopamine depletion imbalances the two major output pathways of the striatum. L-DOPA replacement therapy is believed to correct this imbalance by providing effective D1 ...

D2, but not D1, agonists correct the imbalance between striatonigral and striatopallidal neurons caused by dopaminergic depletion in a rat model of Parkinson's disease

Archive ouverte | Ballion, Bérangère | CCSD

International audience

D2, but not D1, agonists correct the imbalance between striatonigral and striatopallidal neurons caused by dopaminergicdepletion in a rat model of Parkinson’s disease

Archive ouverte | Ballion, Bérangère | CCSD

International audience

Chargement des enrichissements...